journal article·2021-01-13

Photodynamic Coatings on Polymer Microfibers for Pathogen Inactivation: Effects of Application Method and Composition

Bharadwaja S. T. Peddinti, Nicolas Morales-Gagnon, Behnam Pourdeyhimi, Frank Scholle, Richard J. Spontak, Reza A. Ghiladi

Publisher page

Abstract

A substantial increase in the risk of hospital-acquired infections (HAIs) has greatly impacted the global healthcare industry. Harmful pathogens adhere to a variety of surfaces and infect personnel on contact, thereby promoting transmission to new hosts. This is particularly worrisome in the case of antibiotic-resistant pathogens, which constitute a growing threat to human health worldwide and require new preventative routes of disinfection. In this study, we have incorporated different loading levels of a porphyrin photosensitizer capable of generating reactive singlet oxygen in the presence of O2 and visible light in a water-soluble, photo-cross-linkable polymer coating, which was subsequently deposited on polymer microfibers. Two different application methods are considered, and the morphological and chemical characteristics of these coated fibers are analyzed to detect the presence of the coating and photosensitizer. To discern the efficacy of the fibers against pathogenic bacteria, photodynamic inactivation has been performed on two different bacterial strains, Staphylococcus aureus and antibiotic-resistant Escherichia coli, with population reductions of >99.9999 and 99.6%, respectively, after exposure to visible light for 1 h. In response to the current COVID-19 pandemic, we also confirm that these coated fibers can inactivate a human common cold coronavirus serving as a surrogate for the SARS-CoV-2 virus.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Dental Research and COVID-19

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Scott, R. D., II The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention; Centers for Disease Control and Prevention: Atlanta, 2009. www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf.
2. 10.1128/JCM.38.2.724-726.200010.1128/JCM.38.2.724-726.2000 ↗
3. 10.1128/JCM.38.2.724-726.200010.1128/JCM.38.2.724-726.2000 ↗
4. 10.1126/science.aar377710.1126/science.aar3777 ↗
5. Scutti, S. Unusual Forms of ‘Nightmare’ Antibiotic-Resistant Bacteria Detected in 27 States. CNN Health, April 4, 2018. https://www.cnn.com/2018/04/03/health/nightmare-bacteria-cdc-vital-signs/index.html.
6. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States. Department of Health and Human Services, CDC: Atlanta, GA, 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.
7. O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations; Review on Antimicrobial Resistance: London, 2016 (amr-review.org).
8. 10.1371/journal.pone.011836910.1371/journal.pone.0118369 ↗
9. 10.3201/eid2411.18048810.3201/eid2411.180488 ↗
10. 10.1186/s12916-015-0450-010.1186/s12916-015-0450-0 ↗
11. 10.1128/JCM.02004-0810.1128/JCM.02004-08 ↗
12. 10.1016/j.watres.2005.10.03010.1016/j.watres.2005.10.030 ↗
13. 10.1038/nnano.2015.14110.1038/nnano.2015.141 ↗
14. 10.1021/cm050524410.1021/cm0505244 ↗
15. 10.1038/srep0413410.1038/srep04134 ↗
16. 10.1016/j.progpolymsci.2017.03.00110.1016/j.progpolymsci.2017.03.001 ↗
17. 10.1016/j.msec.2015.12.02410.1016/j.msec.2015.12.024 ↗
18. 10.1038/nrmicro177410.1038/nrmicro1774 ↗
19. 10.2217/nnm.11.7810.2217/nnm.11.78 ↗
20. 10.1021/acs.estlett.0c0043710.1021/acs.estlett.0c00437 ↗
21. 10.1016/j.biomaterials.2011.10.02010.1016/j.biomaterials.2011.10.020 ↗
22. 10.1039/C9MH00726A10.1039/C9MH00726A ↗
23. Peddinti, B. S. T.; Downs, S. N.; Yan, J.; Smith, S. D.; Ghiladi, R. A.; Mhetar, V.; Tocchetto, R.; Griffiths, A.; Scholle, F.; Spontak, R. J. Rapid and Repetitive Inactivation of SARS-CoV-2 and Human Coronavirus on Self-Disinfecting Anionic Polymers, submitted for publication.
24. Coronavirus Resource Center, Johns Hopkins University & Medicine, 2020. https://coronavirus.jhu.edu/map.html.
25. 10.1021/acs.biomac.5b0075810.1021/acs.biomac.5b00758 ↗
26. 10.1039/C9GC00551J10.1039/C9GC00551J ↗
27. 10.3390/nano604007710.3390/nano6040077 ↗
28. 10.1016/S1473-3099(16)30268-710.1016/S1473-3099(16)30268-7 ↗
29. 10.1021/es303645n10.1021/es303645n ↗
30. 10.1021/acsami.8b0913910.1021/acsami.8b09139 ↗
31. Peddinti B. S. T. · TPE Int. Mag. · 2019 · 11 · 235
32. 10.1016/j.carbpol.2014.08.10310.1016/j.carbpol.2014.08.103 ↗
33. 10.1002/app.2593910.1002/app.25939 ↗
34. 10.1128/JVI.01755-1510.1128/JVI.01755-15 ↗
35. 10.1002/marc.20160023510.1002/marc.201600235 ↗
36. 10.1111/j.2044-8295.1908.tb00176.x10.1111/j.2044-8295.1908.tb00176.x ↗
37. 10.1007/BF0186391410.1007/BF01863914 ↗
38. 10.1093/cid/cit61310.1093/cid/cit613 ↗
39. 10.1172/JCI6883410.1172/JCI68834 ↗
40. 10.1128/AAC.01289-1310.1128/AAC.01289-13 ↗
41. 10.1093/cid/civ04810.1093/cid/civ048 ↗
42. 10.3201/eid2007.12100410.3201/eid2007.121004 ↗
43. Scutti, S. Second U.S. Patient had Antibiotic-Resistant Superbug Infection. CNN Health, July 12, 2016. https://www.cnn.com/2016/07/12/health/superbug-second-us-patient/.
44. 10.1086/59501110.1086/595011 ↗
45. 10.1542/peds.2018-397810.1542/peds.2018-3978 ↗
46. 10.1016/j.ajic.2019.04.00410.1016/j.ajic.2019.04.004 ↗
47. 10.1056/NEJMc200497310.1056/NEJMc2004973 ↗
48. 10.1016/S2666-5247(20)30003-310.1016/S2666-5247(20)30003-3 ↗
49. 10.1021/acsanm.0c0156210.1021/acsanm.0c01562 ↗
50. 10.3201/eid2606.20041210.3201/eid2606.200412 ↗